We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

IMMNOV

OMX
Main market
Access this stock data via API
Subscribe
Immunovia AB
0
0
0%

Financials

Income statement

Fiscal date Dec 2024 Sep 2024 Jun 2024 Mar 2024
Total reported revenue 455K 235K 85K 156K
Cost of revenue 0 0 0 0
Gross profit 455K 235K 85K 156K
Operating expense
Research & development
Selling general and admin
Other operating expenses 21.8M 17.4M 15.0M 14.4M
Operating income -30.1M -31.2M -23.9M -24.2M
Non operating interest income
Income 33.2M 21.4M
Expense 17K 19.8M 1.7M 147K
Other income expense
Pretax income 3.1M -51.1M -25.6M -2.9M
Tax provision 0 0 0
Net income 3.1M -51.1M -25.6M -2.9M
Basic EPS 0.0 -0.7 -0.3 0.0
Diluted EPS 0.0 -0.7 -0.3 0.0
Basic average shares 169.7M 70.2M 91.2M 91.2M
Diluted average shares 169.7M 70.2M 91.2M 91.2M
EBITDA 4.4M -23.7M -22.3M 181K
Net income from continuing op. -30.1M -31.2M -23.9M -24.2M
Minority interests
Preferred stock dividends 0 0 0 0
Main market

Exchange is currently active.
Closing in 36 minutes

16:53
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:30
All times are displayed in the Europe/Stockholm timezone (CEST, UTC+02:00).